Etanercept Biosimilar GP2015 Has Equivalent Efficacy and Safety to Etanercept Originator in Patients with Moderate to Severe Rheumatoid Arthritis: The Phase 3 Equira Study

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Allanore, Yannick [2 ]
Kucharz, Eugeniusz J. [3 ]
Babic, Goran [4 ]
机构：
[1] Univ Calif San Diego, Med, La Jolla, CA 92093 USA
[2] Paris Descartes Univ, Cochin Hosp, Dept Rheumatol, Paris, France
[3] Med Univ Silesia, Dept Internal Med & Rheumatol, Katowice, Poland
[4] Sandoz Co, Clin Dev, Biopharmaceut, Hexal AG, Holzkirchen, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2797
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy, safety and immunogenicity of the biosimilar etanercept compared to the reference formulation original etanercept in patients with rheumatoid arthritis: An open-label, randomized, comparative, multicenter study
    Pekhenko, Valentyna
    Udovitskiy, Vlad
    Barbukho, Olena
    MEDICINE, 2024, 103 (30)
  • [22] OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY
    Schmalzing, M.
    Askari, A.
    Sheeran, T.
    Jathanakodi, S.
    Both, C.
    Kellner, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1397 - 1397
  • [23] Clinical efficacy and safety of etanercept plus methotrexate or etanercept alone in rheumatoid arthritis patients with inadequate response to methotrexate: The ADORE study
    Taggart, A. J.
    van Riel, P. L. C. M.
    Reynolds, A.
    Sany, J.
    Gaubitz, M.
    Phillips, C.
    Pedersen, R.
    Singh, A.
    MacPeek, D.
    RHEUMATOLOGY, 2006, 45 : I45 - I45
  • [24] Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
    van Riel, P. L. C. M.
    Taggart, A. J.
    Sany, J.
    Gaubitz, M.
    Nab, H. W.
    Pedersen, R.
    Freundlich, B.
    MacPeek, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1478 - 1483
  • [25] REAL-WORLD ASSESSMENT OF GP2015 (ETANERCEPT BIOSIMILAR, SDZ-ETN): AN INTERIM ANALYSIS OF DATA FROM THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE COMPACT STUDY
    Kellner, H.
    Askari, A.
    Kupka, T.
    Friccius-Quecke, H.
    Furlan, F.
    Hachaichi, S.
    Schmalzing, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1445 - 1445
  • [26] EFFICACY AND SAFETY OF SWITCHING FROM ETANERCEPT REFERENCE PRODUCT TO LBEC0101 (ETANERCEPT BIOSIMILAR) COMPARED WITH CONTINUING LBEC0101 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Song, Y. W.
    Matsuno, H.
    Park, M. -C.
    Tomomitsu, M.
    Shin, S.
    Lee, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1389 - 1390
  • [27] A Retrospective Study to Evaluate the Efficacy, Safety, and Drug Survival of Etanercept in Elderly Patients with Rheumatoid Arthritis
    Shah, Alpesh
    Deamude, Melissa
    Mech, Cynthia
    McMurray, Judi
    Bensen, Robert
    Bensen, William
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 959 - 959
  • [28] A randomized double-blind controlled study evaluating the safety and efficacy of etanercept vs etanercept plus anakinra in patients with rheumatoid arthritis
    Genovese, MC
    Cohen, SB
    Moreland, LW
    Lium, D
    Liu, T
    Newmark, R
    Bekker, P
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 66 - 66
  • [29] Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study
    Qingjun Wu
    Yan Zhao
    Dong Xu
    Zhuoli Zhang
    Zhenbin Li
    Scientific Reports, 10
  • [30] Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study
    Wu, Qingjun
    Zhao, Yan
    Xu, Dong
    Zhang, Zhuoli
    Li, Zhenbin
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345